Literature DB >> 8776723

Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.

B R Dey1, K Frick, W Lopaczynski, S P Nissley, R W Furlanetto.   

Abstract

We have used the yeast two-hybrid system to study the interaction between the IGF-I receptor and two putative substrates, IRS-1 and Shc. In addition, we have identified Grb10 as a protein that binds to the insulin-like growth factor I (IGF-I) receptor. This two-hybrid system (the interaction trap) utilizes a hybrid protein containing the LexA DNA-binding domain fused to the intracellular portion of the IGF-I receptor (LexA-IGFIR beta) and hybrids containing an activation domain fused to either IRS-1 (Ad-IRS-1), Shc (Ad-Shc), or a cDNA library. A positive interaction of LexA-IGFIR beta with the activation domain hybrid results in activation of reporter genes, LacZ and LEU2, in the yeast. Western blotting of extracts from transformed yeast demonstrated that the LexA-IGFIR beta fusion protein was expressed and phosphorylated on tyrosine residues. Coexpression of LexA-IGFIR beta with Ad-IRS-1 resulted in strong activation of both reporter genes; activation did not occur with a kinase-negative receptor mutant. IRS-1 residues 160-516 were sufficient for this strong interaction. Coexpression of LexA-IGFIR beta with Ad-Shc also resulted in strong activation of both LacZ and LEU2 reporter genes. This interaction was also dependent upon a tyrosine kinase-active receptor and required tyrosine 950 in the juxtamembrane region of the receptor. An N-terminal fragment of Shc (amino acids 1-232) interacted almost as strongly as full-length Shc whereas the Shc SH2 domain only activated the more sensitive LEU2 reporter. Full-length Shc was phosphorylated on tyrosine when coexpressed with IGFIR beta but not when coexpressed with the kinase-negative receptor mutant. To identify additional proteins that interact with the IGFIRs, a human fetal brain cDNA library was screened using the interaction trap system. This analysis identified partial cDNAs for Grb10. Coexpression of LexA-IGFIR beta with Ad-Grb10 resulted in strong activation of both LacZ and LEU2 reporter genes; this interaction was dependent upon a tyrosine kinase-active receptor but did not require tyrosine 950.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776723     DOI: 10.1210/mend.10.6.8776723

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor.

Authors:  Bin Shi; Deeksha Vishwamitra; J Gabrielle Granda; Thomas Whitton; Ping Shi; Hesham M Amin
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

2.  Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.

Authors:  J Wang; H Dai; N Yousaf; M Moussaif; Y Deng; A Boufelliga; O R Swamy; M E Leone; H Riedel
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.

Authors:  R W Furlanetto; B R Dey; W Lopaczynski; S P Nissley
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 4.  Grb10 is a dual regulator of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Julhash U Kazi
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

Review 5.  Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling.

Authors:  F Liu; R A Roth
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 6.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 7.  Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

Authors:  Hyun Lee; So Ri Kim; Youngman Oh; Seong Ho Cho; Robert P Schleimer; Yong Chul Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Nedd4 controls animal growth by regulating IGF-1 signaling.

Authors:  Xiao R Cao; Nancy L Lill; Natasha Boase; Peijun P Shi; David R Croucher; Hongbo Shan; Jing Qu; Eileen M Sweezer; Trenton Place; Patricia A Kirby; Roger J Daly; Sharad Kumar; Baoli Yang
Journal:  Sci Signal       Date:  2008-09-23       Impact factor: 8.192

9.  FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2012-11-29       Impact factor: 6.603

10.  Transcriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation.

Authors:  B D Stamper; B Mecham; S S Park; H Wilkerson; F M Farin; R P Beyer; T K Bammler; L M Mangravite; M L Cunningham
Journal:  Physiol Genomics       Date:  2012-10-16       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.